Post-Transplant Cyclophosphamide (PTCy) Is Associated with Improved Clinical Outcomes in HLA-Mismatched Unrelated Donor (MMUD) Hematopoietic Stem Cell Transplantation (HCT). The University of Miami Experience

Journal article

Peer reviewed

Transplantation and cellular therapy, Vol.27(3), pp.S238-S239

2021-03

Metrics

5 Record Views

Title: Post-Transplant Cyclophosphamide (PTCy) Is Associated with Improved Clinical Outcomes in HLA-Mismatched Unrelated Donor (MMUD) Hematopoietic Stem Cell Transplantation (HCT). The University of Miami Experience
Creators: Antonio M Jimenez Jimenez
Muhammad Husnain
Deukwoo Kwon
Lazaros J. Lekakis
Denise Pereira
Mark Goodman
Trent P Wang
Amer Beitinjaneh
Thomas Plate
Cara L. Benjamin
Krishna V. Komanduri
Publication Details: Transplantation and cellular therapy, Vol.27(3), pp.S238-S239
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031713413502976